Tate, S. (2005). Development of a new mutation in EGFR leads to drug resistance in non-small cell lung cancer. BMJ Group.
Styl ChicagoTate, S. Development of a New Mutation in EGFR Leads to Drug Resistance in Non-small Cell Lung Cancer. BMJ Group, 2005.
Citace podle MLATate, S. Development of a New Mutation in EGFR Leads to Drug Resistance in Non-small Cell Lung Cancer. BMJ Group, 2005.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..